HESTER BIOSCIENCES
Back to Income Statement
|
HESTER BIOSCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹311 Cr | ₹305 Cr | ₹266 Cr | ₹235 Cr | ₹214 Cr |
What is the latest Revenue of HESTER BIOSCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹311 Cr |
| Mar2024 | ₹305 Cr |
| Mar2023 | ₹266 Cr |
| Mar2022 | ₹235 Cr |
| Mar2021 | ₹214 Cr |
How is Revenue of HESTER BIOSCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹311 Cr | 2.15 | |
| Mar2024 | ₹305 Cr | 14.45 | |
| Mar2023 | ₹266 Cr | 13.23 | |
| Mar2022 | ₹235 Cr | 9.65 | |
| Mar2021 | ₹214 Cr | - | |
Compare Revenue of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,232.5 Cr | 2% | -0.8% | -22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 2% |
-0.8% |
-22.8% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses